SMS, spermine synthase, 6611

N. diseases: 263; N. variants: 9
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0042693
Disease: Violence
Violence
0.010 Biomarker phenotype BEFREE Within an RCT comparing ILM assessment/schedule methods, 162-participants completed daily IVR (n = 81) or SMS (n = 81) assessments measuring 19 substance use and violence (partner/non-partner) behaviors daily for 90-days. 31645000 2020
CUI: C0237123
Disease: Alcohol or Other Drugs use
Alcohol or Other Drugs use
0.010 Biomarker disease BEFREE Within an RCT comparing ILM assessment/schedule methods, 162-participants completed daily IVR (n = 81) or SMS (n = 81) assessments measuring 19 substance use and violence (partner/non-partner) behaviors daily for 90-days. 31645000 2020
CUI: C0403823
Disease: Asthenozoospermia
Asthenozoospermia
0.010 GeneticVariation disease BEFREE In addition, RT-qPCR results revealed that the expression levels of 4 genes coding fructokinase (FRK), citrate synthase (CS), succinate dehydrogenase (SDH), and spermine synthase (SMS), which were related to energy metabolism, were decreased in the AS group. 31808565 2020
CUI: C0424605
Disease: Developmental delay (disorder)
Developmental delay (disorder)
0.010 Biomarker phenotype BEFREE We hypothesized that the SRS-22 is appropriate for children with EOS from CS who do not have a diagnosis of developmental delay. 31157754 2020
CUI: C0557874
Disease: Global developmental delay
Global developmental delay
0.010 Biomarker disease BEFREE We hypothesized that the SRS-22 is appropriate for children with EOS from CS who do not have a diagnosis of developmental delay. 31157754 2020
CUI: C0559260
Disease: Congenital scoliosis
Congenital scoliosis
0.010 Biomarker disease BEFREE A prospective institutional CS database was queried to identify patients who had the EOSQ-24 and SRS-22 completed at the same time point. 31157754 2020
CUI: C0006118
Disease: Brain Neoplasms
Brain Neoplasms
0.010 Biomarker group BEFREE Level 3: Surgery plus SRS is recommended to provide survival benefit in patients with metastatic brain tumors Level 3: Multimodal treatments including either surgery + WBRT + SRS boost or surgery + WBRT are recommended as alternatives to WBRT + SRS in terms of providing overall survival and local control benefits. 30629227 2019
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.010 AlteredExpression disease BEFREE In the present study, a sulfated glucuronorhamnoxylan polysaccharide (named SPS-CF) purified from a green alga Capsosiphon fulvescens was evaluated for its anti-cancer activity in vitro and in vivo against colorectal cancer. 30521889 2019
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.010 Biomarker disease BEFREE SMS reminders sent to CF patients might improve influenza vaccine uptake. 30192711 2019
CUI: C0014536
Disease: Epidural Neoplasms
Epidural Neoplasms
0.010 Biomarker group BEFREE "Separation" of the ventral epidural tumor component anteriorly creates space for concomitant SRS while a simple laminectomy would not adequately achieve this goal. 29889256 2019
CUI: C0014556
Disease: Epilepsy, Temporal Lobe
Epilepsy, Temporal Lobe
0.010 Biomarker disease BEFREE We established that oral CBD attenuated the time-dependent increase in seizure burden and improved TLE-associated motor comorbidities of epileptic rats in the RISE-SRS model without affecting gait. 30588604 2019
CUI: C0016667
Disease: Fragile X Syndrome
Fragile X Syndrome
0.010 Biomarker disease BEFREE We carried out a psychometric assessment of the Social Communication Questionnaire (SCQ) and the Social Responsiveness Scale (SRS-2) in fragile X syndrome (FXS), relative to clinician DSM5-based diagnosis of autism spectrum disorder (ASD) in FXS. 31342442 2019
CUI: C0020255
Disease: Hydrocephalus
Hydrocephalus
0.010 Biomarker disease BEFREE We conducted a meta-analysis of databases PubMed and Cochrane to identify all articles for the period January 2000-August 2018 with the following inclusion criteria: (1) VS treated with single fraction SRS (2) > 10 patients (3) original reports only (4) hydrocephalus reported as complication (5) human study. 31621039 2019
CUI: C0021390
Disease: Inflammatory Bowel Diseases
Inflammatory Bowel Diseases
0.010 Biomarker group BEFREE In this study, patients attending 3 tertiary referral centers with worsening IBD symptoms in the previous 2 years were eligible for randomization to remote monitoring via SMS text messages (short message service, SMS) every other week, weekly, or standard care. 31162128 2019
CUI: C0024031
Disease: Low Back Pain
Low Back Pain
0.010 Biomarker phenotype BEFREE The primary outcome of the trial was the total number of days with bothersome LBP collected weekly for 12 months using an automated SMS system. 31600269 2019
CUI: C0024117
Disease: Chronic Obstructive Airway Disease
Chronic Obstructive Airway Disease
0.010 Biomarker disease BEFREE Whether web-based support in addition to prompts (email and SMS) could be used to promote self-management strategies to facilitate behaviour change in people with COPD is not clear. 31594889 2019
CUI: C0027809
Disease: Neurilemmoma
Neurilemmoma
0.010 Biomarker disease BEFREE Texture feature analysis helps to predict permanent versus transient enlargement and final volume reduction of schwannomas after SRS. 31493607 2019
CUI: C0031572
Disease: Phobia, Social
Phobia, Social
0.010 Biomarker disease BEFREE The SPS-6 scores ≥9 and SIAS-6 scores ≥12 were considered indicative of social phobia and social interaction anxiety, respectively. 31675602 2019
CUI: C0034067
Disease: Pulmonary Emphysema
Pulmonary Emphysema
0.010 Biomarker disease BEFREE The SMS distribution over the different lung regions showed a distinct pattern suggesting that emphysema due to severe AATD develops from basal to central and ultimately apical regions. 30819163 2019
CUI: C0037933
Disease: Spinal Diseases
Spinal Diseases
0.010 GeneticVariation group BEFREE This study further assesses the validity of the SRS-30 by comparing its results with other HRQoL instruments, such as Oswestry disability index (ODI) and the RAND-36, among unselected adult patients with degenerative spinal disorder. 31106613 2019
CUI: C0038220
Disease: Status Epilepticus
Status Epilepticus
0.010 Biomarker disease BEFREE RESULTS We concluded that EGCG treatment after SE (1) markedly reduced SRS frequency in pilocarpine-treated rats, (2) improved epilepsy-induced cognitive impairment and reversed epilepsy-induced synaptic dysfunction in L-LTP in vivo, (3) protected hippocampal neurons from damage after SRS, and (4) significantly attenuated the increase in TRL-4 and IL-1ß hippocampal levels. 30843525 2019
CUI: C0038454
Disease: Cerebrovascular accident
Cerebrovascular accident
0.010 Biomarker group BEFREE In conclusion, it seems that this type of SMS-based reminder systems could be of good use in the rehabilitation process after stroke, even in low income counties where few clients have access to Internet or smart phones, and where access to healthcare services is limited. 31269946 2019
CUI: C0040997
Disease: Trigeminal Neuralgia
Trigeminal Neuralgia
0.010 Biomarker disease BEFREE This study provides prospective data after whole nerve encompassing LINAC-SRS for trigeminal neuralgia. 30877350 2019
CUI: C0152444
Disease: Hydrorhachis
Hydrorhachis
0.010 GeneticVariation disease BEFREE In evaluating the subareas of the SRS-22 test, we found that the "function" scores differed significantly by comparing normal (21.5±1.6) and hydromyelia (20.4±1.8) patients (P<0.05). 30913042 2019
CUI: C0221757
Disease: alpha 1-Antitrypsin Deficiency
alpha 1-Antitrypsin Deficiency
0.010 Biomarker disease BEFREE The SMS distribution over the different lung regions showed a distinct pattern suggesting that emphysema due to severe AATD develops from basal to central and ultimately apical regions. 30819163 2019